常规临床实践中银屑病严重程度的定义:现行指南未能捕捉长期银屑病管理的复杂性
基于德国200余家皮肤科诊所和医院的3274例银屑病患者横断面数据,分析不同严重程度定义对中重度银屑病比例的影响。符合欧洲共识标准(PASI且DLQI>10)者仅14.0%,而满足PASI或DLQI>10者达45.3%。将所有使用系统药物者视为中重度可使比例升至56.9%和75.2%。作者提出需国际标准化以改善治疗和医疗规划。
要点
- 按欧洲共识标准(PASI且DLQI>10)仅14.0%患者为中重度。
- 满足PASI或DLQI>10者达45.3%,远高于两者同时满足。
- 将所有系统治疗者视为中重度时比例升至56.9%和75.2%。
核心结论
- 接受皮肤科治疗的银屑病患者中,中重度比例因定义不同而差异显著,导致系统治疗可及性的不确定性和不公平。
- 作者提出应进行国际标准化,以更可靠地进行治疗和医疗规划。
研究设计与样本
- 横断面分析,数据来自德国200余家皮肤科诊所和医院的3274例银屑病患者,基于PASI和DLQI评估疾病严重程度。
主要发现
- 符合欧洲共识标准(PASI且DLQI>10)的中重度银屑病患者比例为14.0%。
- 达到PASI或DLQI>10的患者比例为45.3%。
- 将所有使用系统药物者视为中重度时,上述比例分别升至56.9%和75.2%。
- 仅使用PASI>10定义时,中重度患者比例分别为35.3%和69.3%。
关键数值与推荐
- 欧洲共识标准:中重度银屑病定义为PASI且DLQI>10。
- 替代定义包括PASI或DLQI>10、仅PASI>10、以及将所有系统治疗者视为中重度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Assessment of disease severity is an essential component of psoriasis management. Moderate-to-severe disease qualifies for systemic treatment but different definitions are used. OBJECTIVES: To analyse the impact of different severity definitions for psoriasis in real-world healthcare. METHODS: Cross-sectional data on 3274 patients with psoriasis from more than 200 dermatology offices and clinics across Germany were analysed for disease severity based on Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI). The proportions of patients having moderate-to-severe disease were determined accordingly. RESULTS: The proportion of patients meeting the European consensus criteria for moderate-to-severe psoriasis (PASI AND DLQI > 10) was 14·0%, although 45·3% attained at least PASI OR DLQI > 10. Consideration of all patients on systemic drugs as being 'moderate-to-severe' increased these proportions to 56·9% and 75·2%, respectively. When only PASI > 10 was used, moderate-to-severe disease affected 35·3% and 69·3%, respectively. CONCLUSIONS: The proportion of patients with psoriasis under dermatological care considered to have moderate-to-severe disease varies considerably according to how the latter is defined, resulting in uncertainty and inequity of access to systemic therapy. We propose an international standardisation in this for the sake of more reliable treatment and healthcare planning.
引用
- Augustin M, Langenbruch A, Gutknecht M, et al. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management. Br J Dermatol. 2018. PMID: 30334253. doi:10.1111/bjd.17128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。